Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New data from Phase 3 studies provide additional evidence supporting treatment effect for oral BG-12 (dimethyl fumarate) in multiple sclerosis
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
Dimethyl fumarate regulates histone deacetylase expression in astrocytes.
Myelin Gordon Research Conference
Central nervous system neuroinflammatory disorders in Asian/Pacific regions.
Development of a Bilingual MS-Specific Health Classification System: The Preference-Based Multiple Sclerosis Index.
Salvianolic acid B protects the myelin sheath around injured spinal cord axons.
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: Electrophysiological evidence.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
Drugs@FDA
Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients.
Comparative effectiveness of early Natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis.
A Complex Case of Neuro-Behçet's Disease in a Patient Previously Diagnosed with multiple Sclerosis: A Case Report.
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
EU regulator warns on possible MS drugs side effects
Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Radiologically isolated syndrome: 5-year risk for an initial clinical event.
MicroRNAs: The Role in Autoimmune Inflammation.
A Safety and Efficacy Extension Study of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies.
Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: A randomized clinical trial.
Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.

Pages